These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1982833

  • 1. One year experience with subcutaneous human erythropoietin in CAPD: correction of renal anemia and increased ultrafiltration.
    Lubrich-Birkner I, Schollmeyer P, Steinhauer HB.
    Adv Perit Dial; 1990; 6():302-7. PubMed ID: 1982833
    [Abstract] [Full Text] [Related]

  • 2. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

  • 3. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 4. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991 Nov; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Chung WW, Leung CB, Chan K, Lai KN.
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Jan; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A, Paoletti E, Molinelli G.
    Adv Perit Dial; 1990 Jan; 6():292-5. PubMed ID: 1982830
    [Abstract] [Full Text] [Related]

  • 9. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 Jan; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 10. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K, Lubom JA, Collier L, Fleming D, Work J.
    Adv Perit Dial; 1994 Jan; 10():124-8. PubMed ID: 7999809
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992 Jan; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 12. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999 Jan; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

  • 13. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO.
    Vega N, Fernandez A, Hortal L, Macias M, Rodriguez JC, Plaza C, Perdomo M, Vega R, Palop L.
    Adv Perit Dial; 1992 Jan; 8():467-70. PubMed ID: 1361850
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT, Prata MM, Barbas JV, dos Santos JP.
    Acta Med Port; 1990 Jan; 3(6):347-52. PubMed ID: 2089856
    [Abstract] [Full Text] [Related]

  • 15. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B, Selgas R, Riñon C, Fernandez-Zamorano A, Borrego F, Ortuño F, Lopez-Revuelta K, Torre A, Sanchez Sicilia L.
    Adv Perit Dial; 1990 Jan; 6():296-301. PubMed ID: 1982831
    [Abstract] [Full Text] [Related]

  • 16. Once weekly subcutaneous erythropoietin is an effective maintenance therapy in the treatment of anemia of end stage renal disease in patients on CAPD.
    Saleh A, Krane NK, Caballero M, Starks E.
    Adv Perit Dial; 1991 Jan; 7():288-91. PubMed ID: 1680448
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [Abstract] [Full Text] [Related]

  • 18. Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.
    Faller B, Slingeneyer A, Waller M, Michel C, Grützmacher P, Müller HP, Barany P, Grabensee B, Issad B, Schmitt H.
    Clin Nephrol; 1993 Sep; 40(3):168-75. PubMed ID: 8403573
    [Abstract] [Full Text] [Related]

  • 19. The use of subcutaneous erythropoietin in CAPD patients.
    Piraino B, Johnston JR.
    Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907
    [Abstract] [Full Text] [Related]

  • 20. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.